Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania

被引:2
|
作者
Codreanu, Catalin [1 ,2 ]
Mogosan, Corina [1 ,2 ]
Popescu, Claudiu [1 ,2 ]
Paveliu, Marian-Sorin [3 ]
机构
[1] Dr Ion Stoia Clin Ctr Rheumat Dis, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Bucharest, Romania
[3] Titu Maiorescu Univ, Fac Med, Bucharest, Romania
关键词
MODIFYING ANTIRHEUMATIC DRUGS; INDIRECT MEDICAL COSTS; OF-ILLNESS; PROGRESSION; RECOMMENDATIONS; CONSEQUENCES;
D O I
10.1155/2019/9343812
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rheumatoid arthritis (RA) is associated with increased costs generated by resource utilization and loss of work productivity. We have studied 206 RA patients and analyzed indirect costs of RA in Romania (estimated using the human capital approach) in comparison with reported data for other countries. Data were collected using self-reported questionnaires. The average age at inclusion was 55 years, with mean disease duration of 9.4 years; 55 patients had permanent work disability due to RA; 6.35 days of sick leave per patient were reported for the entire year of follow-up; the cost of permanent work disability was 1256(sic) per patient. From a societal perspective, the average indirect costs for a patient with RA were 1506(sic), significantly lower than the ones reported by other countries, especially due to the low monetary value of paid work.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] INDIRECT COSTS OF RHEUMATOID ARTHRITIS AND THEIR DETERMINANTS
    Maurel, F.
    Bardoulat, I
    Camara, C.
    Law, Schadtler L.
    Le Pen, C.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A444 - A445
  • [2] Indirect costs of rheumatoid arthritis in Brazil
    Cordeiro de Azevedo, Ana Beatriz
    Ferraz, Marcos Bosi
    Ciconelli, Rozana Mesquita
    [J]. VALUE IN HEALTH, 2008, 11 (05) : 869 - 877
  • [3] Rheumatoid arthritis: direct and indirect costs
    Rat, AC
    Boissier, MC
    [J]. JOINT BONE SPINE, 2004, 71 (06) : 518 - 524
  • [4] Direct and indirect costs of rheumatoid arthritis to an employer
    Birnbaum, HG
    Barton, M
    Greenberg, PE
    Sisitsky, T
    Auerbach, R
    Wanke, LA
    Buatti, MC
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2000, 42 (06) : 588 - 596
  • [5] INDIRECT COSTS ASSOCIATED WITH RHEUMATOID ARTHRITIS IN TURKEY
    Hamuryudan, V
    Direskeneli, H.
    Ertenli, I
    Inanc, M.
    Karaaslan, Y.
    Oksel, F.
    Ozbek, S.
    Pay, S.
    Terzioglu, E.
    Durguner, B.
    Baser, O.
    Akkoc, N.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A443 - A443
  • [6] Direct and indirect costs of rheumatoid arthritis to an employer.
    Birnbaum, H
    Greenberg, P
    Sistisky, T
    Barton, M
    Wanke, LA
    Buatti, M
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S326 - S326
  • [7] DIRECT AND INDIRECT COSTS OF RHEUMATOID ARTHRITIS MANAGEMENT IN POLAND
    Ruszkowski, J.
    Lesniowska, J.
    Gierczynski, J.
    Lis, J.
    Glasek, M.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A438 - A438
  • [8] Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis
    Newhall-Perry, K
    Law, NJ
    Ramos, B
    Sterz, M
    Wong, WK
    Bulpitt, KJ
    Park, G
    Lee, M
    Clements, P
    Paulus, HE
    [J]. JOURNAL OF RHEUMATOLOGY, 2000, 27 (05) : 1156 - 1163
  • [9] Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey
    Hamuryudan, V.
    Direskeneli, H.
    Ertenli, I.
    Inanc, M.
    Karaaslan, Y.
    Oksel, F.
    Ozbek, S.
    Pay, S.
    Terzioglu, E.
    Tezer, D. Balkan
    Hacibedel, B.
    Akkoc, N.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : 1033 - 1037
  • [10] The need for standardization: A literature review of indirect costs of rheumatoid arthritis and osteoarthritis
    Xie, Feng
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (07): : 1027 - 1033